Cargando…

Performance of a multisensory implantable cardioverter-defibrillator algorithm for remote heart failure management: the RE-HEART registry

BACKGROUND: The HeartLogic algorithm measures data from multiple implantable cardioverter-defibrillator-based (ICD) sensors and combines them into a single index. The associated alert has proved to be a sensitive and timely predictor of impending heart failure (HF) decompensation. OBJECTIVE: To anal...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Juan Baguda, J, Pachon Iglesias, M, Gavira Gomez, J J, Martinez Mateo, V, Arcocha Torres, M F, Iniesta Manjavacas, A M, Rivas Gandara, N, Alonso Salinas, G L, Goirigolzarri Artaza, J J, Macias Gallego, A M, Medina Moreno, O, Martinez Martinez, J G, Rubin Lopez, J M, Cozar Leon, R, Salguero Bodes, R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707889/ http://dx.doi.org/10.1093/ehjdh/ztab104.3092

Ejemplares similares

Assessment of heart failure parameters by telemonitoring patients with an implantable cardioverter defibrillator
por: Fily, M, et al.
Publicado: (2022)

Implantable cardioverter-defibrillators in congenital heart disease
por: Chubb, H., et al.
Publicado: (2016)

Clinical Utility of HeartLogic, a Multiparametric Telemonitoring System, in Heart Failure
por: López-Azor, Juan Carlos, et al.
Publicado: (2022)

The Automatic External Cardioverter-Defibrillator
por: Martínez-Rubio, Antoni, et al.
Publicado: (2004)

Remote Monitoring of Heart Failure in Patients with Implantable Cardioverter-Defibrillators: Current Status and Future Needs
por: Theuns, Dominic A. M. J., et al.
Publicado: (2021)

Implantable Cardioverter-defibrillators in Adult Congenital Heart Disease
por: Stewart, Merrill H., et al.
Publicado: (2018)

Implantable Cardioverter-Defibrillator Lead in an Explanted Human Heart
por: Jeong, Hyung Ki, et al.
Publicado: (2022)

Role of deep learning methods in screening for subcutaneous implantable cardioverter defibrillator in heart failure
por: ElRefai, Mohamed, et al.
Publicado: (2022)

First experience with the wearable cardioverter defibrillator in the Netherlands
por: Knops, R. E., et al.
Publicado: (2011)

Efficacy of an implantable cardioverter-defibrillator in patients with diabetes and heart failure and reduced ejection fraction
por: Rørth, Rasmus, et al.
Publicado: (2019)

Avoiding Untimely Implantable Cardioverter/Defibrillator Implantation by Intensified Heart Failure Therapy Optimization Supported by the Wearable Cardioverter/Defibrillator—The PROLONG Study
por: Duncker, David, et al.
Publicado: (2017)

Eligibility for subcutaneous implantable cardioverter‐defibrillator in adults with congenital heart disease
por: Zormpas, Christos, et al.
Publicado: (2021)

Improvements in 25 Years of Implantable Cardioverter Defibrillator Therapy
por: van Welsenes, G. H., et al.
Publicado: (2010)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Association Between Comorbidities and Outcomes in Heart Failure Patients With and Without an Implantable Cardioverter-Defibrillator for Primary Prevention
por: Khazanie, Prateeti, et al.
Publicado: (2015)

The role of implantable cardioverter-defibrillators in New York Heart Class I heart failure patients: do not abandon the asymptomatic just yet
por: van der Lingen, Anne-Lotte C J, et al.
Publicado: (2020)

Implantable Cardioverter-defibrillator Use in Structural Heart Disease: Narrowing the Playing Field
por: Ellis, Christopher R.
Publicado: (2018)

Deactivation of implantable cardioverter defibrillator in Japanese patients with end‐stage heart failure
por: Nakazawa, Mayui, et al.
Publicado: (2020)

Implantable cardioverter-defibrillator in patients awaiting heart transplantation: Reinforcing the bridge to transplant
por: Ariyaratnam, Jonathan P., et al.
Publicado: (2021)

Depressive Symptoms and Quality of Life in Patients With Heart Failure and an Implantable Cardioverter-Defibrillator
por: Zormpas, Christos, et al.
Publicado: (2022)

Evolving use and indications for implantable cardioverter defibrillators
por: de Groot, J. R.
Publicado: (2018)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort
por: van Barreveld, Marit, et al.
Publicado: (2021)

Body Piercing with a Metallic Tongue Stud Resulting in Ineffective Implantable Cardioverter-defibrillator Shocks: “Heart to Mouth”
por: Singh, Manavotam, et al.
Publicado: (2021)

A broken lead to an open heart: implantable cardioverter defibrillator vegetations with lead fracture
por: Horani, George, et al.
Publicado: (2021)

Telemonitoring Potential of Wearable Cardioverter-Defibrillators during the Follow-Up of Patients with Heart Failure
por: Blockhaus, Christian, et al.
Publicado: (2022)

Assessing physical activity with the wearable cardioverter defibrillator in patients with newly diagnosed heart failure
por: Iliodromitis, Konstantinos, et al.
Publicado: (2023)

Subcutaneous implantable cardioverter-defibrillator generator removal: a multicenter analysis
por: Luker, J, et al.
Publicado: (2023)

Validity of device-measured activity in patients with an implantable cardioverter-defibrillator
por: Kolk, M Z H, et al.
Publicado: (2023)

Should mechanical dyssynchrony be assessed in patients with implantable cardioverter-defibrillators?
por: Boogers, Mark J., et al.
Publicado: (2010)

Usage of the wearable cardioverter-defibrillator during pregnancy
por: Olic, J.-Jacqueline, et al.
Publicado: (2022)

Role of Implantable Cardioverter Defibrillators in the Treatment of Hypertrophic Cardiomyopathy
por: Ghosh, Joydeep, et al.
Publicado: (2005)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Association between mortality and implantable cardioverter‐defibrillators by aetiology of heart failure: a propensity‐matched analysis of the WARCEF trial
por: Lee, Tetz C., et al.
Publicado: (2019)

Optimizing patient selection for primary prevention implantable cardioverter-defibrillator implantation: utilizing multimodal machine learning to assess risk of implantable cardioverter-defibrillator non-benefit
por: Kolk, Maarten Z H, et al.
Publicado: (2023)

Premature ventricular contractions in patients with an implantable cardioverter defibrillator cardiac resynchronization therapy device: Results from the UMBRELLA registry
por: Akerström, Finn, et al.
Publicado: (2020)

Stenotrophomonas maltophilia Endocarditis of an Implantable Cardioverter Defibrillator Lead
por: Satish, Mohan, et al.
Publicado: (2019)

Implantable cardioverter defibrillator during laser transurethral resection of the prostate
por: Deroee, A F, et al.
Publicado: (2014)

Capsule endoscopy in patients with cardiac pacemakers, implantable cardioverter defibrillators and left heart assist devices
por: Bandorski, Dirk, et al.
Publicado: (2014)

Use of Implantable Cardioverter Defibrillators in Heart Failure Patients and Risk of Mortality: A Meta-Analysis
por: Zhang, Yucong, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_tvpcvu0gomkf7m7vgrcum7mh4r